Not applicableLooking for participantsNCT02434445
What this trial is testing
Use of Novel Plasma and Urinary Biomarkers to Predict the Development of Hepatorenal Syndrome in Cirrhotic Patients
Who this might be right for
Hepatorenal Syndrome
The University of Hong Kong 100